|Roanna Clarissa Ruiz||analyst|
Good afternoon, and welcome to Enanta Pharmaceuticals Fiscal Fourth Quarter and Year-End Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded. I would now like to turn the conference to your host Ms. Jennifer Viera, Investor Relations. Please go ahead.
Thank you, operator, and thanks to everyone for joining us this afternoon.